MX9604899A - X-ray contrast compositions containing pharmaceutically acceptable clays. - Google Patents

X-ray contrast compositions containing pharmaceutically acceptable clays.

Info

Publication number
MX9604899A
MX9604899A MX9604899A MX9604899A MX9604899A MX 9604899 A MX9604899 A MX 9604899A MX 9604899 A MX9604899 A MX 9604899A MX 9604899 A MX9604899 A MX 9604899A MX 9604899 A MX9604899 A MX 9604899A
Authority
MX
Mexico
Prior art keywords
pharmaceutically acceptable
ray contrast
compositions containing
containing pharmaceutically
contrast compositions
Prior art date
Application number
MX9604899A
Other languages
Spanish (es)
Other versions
MXPA96004899A (en
Inventor
Stephen B Ruddy
Gregory L Mcintire
Mary E Roberts
John Toner
Edward R Bacon
Tom Caulfield
Eugene R Cooper
Brent D Douty
Carl R Illig
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/230,580 external-priority patent/US5476646A/en
Priority claimed from US08/236,287 external-priority patent/US5424056A/en
Priority claimed from US08/237,502 external-priority patent/US5492687A/en
Priority claimed from US08/239,090 external-priority patent/US5484585A/en
Priority claimed from US08/247,438 external-priority patent/US5531979A/en
Priority claimed from US08/247,424 external-priority patent/US5360604A/en
Priority claimed from US08/249,424 external-priority patent/US5472682A/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of MX9604899A publication Critical patent/MX9604899A/en
Publication of MXPA96004899A publication Critical patent/MXPA96004899A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Disclosed are x-ray contrast compositions for oral or retrograde examination of the gastrointestinal tract comprising an x-ray contrast producing agent in combination with a pharmaceutically acceptable clay in a pharmaceutically acceptable carrier; and methods for their use in diagnostic radiology of the gastrointestinal tract.
MXPA/A/1996/004899A 1994-04-21 1996-10-17 Compositions of contrast for x-rays containing clays pharmaceutically accepted MXPA96004899A (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US239090 1981-02-27
US08/230,580 US5476646A (en) 1992-05-01 1994-04-21 X-ray contrast compositions containing iodophenoxyalkanes and pharmaceutically acceptable clays
US230580 1994-04-21
US08/236,287 US5424056A (en) 1993-03-01 1994-04-29 X-ray contrast compositions containing iodoaniline derivatives and pharmaceutically acceptable clays
US236287 1994-04-29
US237502 1994-05-03
US08/237,502 US5492687A (en) 1993-03-11 1994-05-03 Compositions of iodophenoxy alkylene ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/239,090 US5484585A (en) 1993-03-11 1994-05-05 Compositions of iodobenzoic acid derivatives and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US247438 1994-05-23
US08/247,438 US5531979A (en) 1993-02-02 1994-05-23 Compositions of iodophenoxy alkanes and iodophenyl ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/247,424 US5360604A (en) 1994-04-14 1994-05-23 X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays
US249424 1994-05-26
US08/249,424 US5472682A (en) 1993-03-31 1994-05-26 Compositions of iodophenyl esters and iodophenyl sulfonates and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
PCT/GB1995/000566 WO1995028969A1 (en) 1994-04-21 1995-03-16 X-ray contrast compositions containing pharmaceutically acceptable clays
US247424 2002-09-19

Publications (2)

Publication Number Publication Date
MX9604899A true MX9604899A (en) 1998-03-31
MXPA96004899A MXPA96004899A (en) 1998-10-15

Family

ID=

Also Published As

Publication number Publication date
EP0756497A1 (en) 1997-02-05
WO1995028969A1 (en) 1995-11-02
HU9602908D0 (en) 1996-12-30
JPH09512029A (en) 1997-12-02
AU1897795A (en) 1995-11-16
NO964451D0 (en) 1996-10-18
NO964451L (en) 1996-12-18
CA2187019A1 (en) 1995-11-02
HUT76304A (en) 1997-07-28
FI964212A0 (en) 1996-10-18
FI964212A (en) 1996-10-18
CN1147206A (en) 1997-04-09

Similar Documents

Publication Publication Date Title
US4685883A (en) Local delivery of chemotherapeutic agents for the treatment of periodontal disease
AU4471796A (en) Oral gastrointestinal diagnostic x-ray contrast agents in combination with pharmaceutically acceptable clays and surfactants
EP1208582A4 (en) Miniature x-ray source and flexible probe
AU5864296A (en) Diagnostic imaging x-ray contrast agents
AU4471896A (en) Oral gastrointestinal x-ray contrast agents in combination with surfactants
AU4764396A (en) Calcium/oxyanion-containing particles for use in medical diagnostic imaging
SG46275A1 (en) X-ray radiographic apparatus for medical use
AU6762198A (en) Medical uses of focused and imaged x-rays
AU5674999A (en) Information storage and transmittal for medical diagnostic devices
ZA982968B (en) Compositions and methods for the treatment and diagnosis of breast cancer
HUP0600501A3 (en) Use of cs-866 for producing pharmaceutical composition for the treatment of arteriosclerosis
DE69314860T2 (en) Mammography method and mammography x-ray tube
NO964451L (en) X-ray contrast compositions containing pharmaceutically acceptable clays
NO940115D0 (en) Contrast agents for X-ray and magnetic tomographic imaging
GB9902252D0 (en) X-ray filter and x-ray examination apparatus using the same
EP0360266A3 (en) Barium sulfate contrast medium for x-ray examination of the large intestine
AU1214995A (en) Cdna probe for breast cancer diagnosis and treatment
IL121084A0 (en) Compositions and methods for diagnosis of tumors by X-ray imaging
HUP9801495A3 (en) X-ray examination apparatus provided with a tiltable patient table
MX9603611A (en) X-ray contrast compositions containing cellulose derivatives.
AU2823795A (en) 2,4,6-triiodo-5-substituted-amino-isophthalate esters useful as x-ray contrast agents for medical diagnostic imaging
MX9302501A (en) RADIOGRAPHIC CONTRAST COMPOSITIONS AND METHODS FOR USE IN VISUALIZATION OF INTESTINAL DUCT
AU3436295A (en) Diagnostic imaging agent
DE69509478D1 (en) X-ray image intensifier and its manufacturing process
MX9305314A (en) CONTRAST COMPOSITIONS FOR X-RAYS CONTAINING A NEIGHBORHOOD SALT AND FILM FORMING MATERIALS.